4//SEC Filing
Freddo James L 4
Accession 0001209191-09-041455
CIK 0001128495other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:47 PM ET
Size
5.9 KB
Accession
0001209191-09-041455
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2009-08-18+35,000→ 35,000 totalExercise: $2.24From: 2010-02-18Exp: 2019-08-17→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable six months from the date of grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next 18 months such that all shares subject to the option will be fully vested and exercisable as of August 18, 2011.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeother
Related Parties
1- filerCIK 0001368924
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:47 PM ET
- Size
- 5.9 KB